Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 16 of 25

COMPLETED Phase 1

Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation

NCT02068872

COMPLETED NA

A Mobile Behavioral Monitoring Intervention for Bipolar Disorder

NCT02405117

COMPLETED NA

Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)

NCT02026908

COMPLETED

Central Venous Catheter Insertion Train the Trainer

NCT02402257

TERMINATED Phase 2

Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis

NCT02382588

COMPLETED NA

Promoting Cholesterol Screening

NCT01930149

COMPLETED

Can Oxytocin Level Predict Postpartum Depression?

NCT02020148

COMPLETED NA

Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer

NCT01811264

TERMINATED Phase 4

Analgesic Benefits of Genicular Nerve Blocks of the Posterior Knee for Patients Undergoing ACL Reconstruction

NCT02008617

COMPLETED Phase 2

Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

NCT01898130

COMPLETED Phase 4

Effects of Tolvaptan in Healthy Adults

NCT01973140

COMPLETED NA

A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections

NCT01981174

COMPLETED NA

Sun Protection of Kidney Transplant Recipients

NCT01646099

COMPLETED Phase 4

Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study

NCT01997515

COMPLETED

Goals of Care Discussions for Hospitalized Patients With Advanced Cancer

NCT01991015

COMPLETED NA

Perioperative Systemic Acetaminophen to Improve Postoperative Quality of Recovery After Ambulatory Breast Surgery

NCT01852955

COMPLETED Phase 4

Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain

NCT02024724

COMPLETED NA

A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma

NCT01976273

COMPLETED

Adaption of the Skin Sun Sensitivity Scale

NCT01975038

COMPLETED NA

Maximizing Language Development in Children With Hearing Loss

NCT01963468

COMPLETED NA

Optimizing Kidney Transplant Informed Consent

NCT01859884

COMPLETED NA

The Viability of Short Stems in Total Hip Arthroplasty

NCT02577822

COMPLETED

The PreNAPS Study: FI, Nutrition, and Psychosocial Health Outcomes at Gulu Regional Referral Hospital

NCT02922829

COMPLETED Phase 1

Nicardipine vs Esmolol Craniotomy Emergence

NCT01951950

COMPLETED

Pregnant Women Taking Lamictal for Bipolar Disorder

NCT01996293

COMPLETED

Contrast Enhanced PA Pressure Measurements

NCT06240871

COMPLETED Phase 2

Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity

NCT01814072

TERMINATED Phase 4

Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain

NCT02385266

COMPLETED NA

Nanocytology Test to Evaluate Skin Cancer in High Risk Patients

NCT01905891

COMPLETED Phase 2

Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01853644

COMPLETED NA

Study of Skin and Muscle Parameters Using a Skin Sensor

NCT01722929

COMPLETED NA

A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use

NCT01669473

COMPLETED

Mild Cognitive Impairment in Breast Cancer Patients

NCT01949376

COMPLETED NA

Evaluation of Sun Protection Education for Kidney Transplant Recipients

NCT01844713

COMPLETED NA

Enlighten: An Adaptive Technology Weight Loss Intervention

NCT01855932

COMPLETED NA

Evaluation of a Website on Living Kidney Donation for Hispanics

NCT01859871

COMPLETED NA

Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men

NCT01836445

TERMINATED Phase 2

Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness

NCT01844726

COMPLETED NA

Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery

NCT01927302

COMPLETED NA

Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma

NCT01859845

TERMINATED Phase 1

Collagen Injections for the Treatment of Acne Scars and Wrinkles

NCT01704209

TERMINATED Phase 1

Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma

NCT01738594

COMPLETED Phase 2

A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas

NCT01782313

TERMINATED Phase 1

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

NCT01805037

COMPLETED NA

SRL (Sirolimus) Withdrawal

NCT02062944

COMPLETED

Alcohol Biomarkers in Post-Liver Transplant Patients

NCT01812226

COMPLETED Early Phase 1

Cabergoline in Metastatic Breast Cancer

NCT01730729

COMPLETED NA

NEAT! Technology to Increase Breaks in Sedentary Behavior in Adults With Diabetes

NCT01754467

COMPLETED NA

Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea

NCT01785303

COMPLETED NA

Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

NCT01653847

← Previous Page 16 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.